AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study

Recruitingn/aAges 18 Years - 75 YearsAllFundació Institut de Recerca de l'Hospital de la …
💬

In plain words

What the trial is, and whether it could suit you

The aim of this qualitative study is to explore and identify the expectations, perceptions, attitudes, needs, and knowledge related to the management of metabolic dysfunction-associated steatohepatitis (MASH) in patients diagnosed with this condition, before and after their participation in the MASH-Cardiovascular Programme at Hospital de la Santa Creu i Sant Pau, Barcelona. The main research question is: What expectations, attitudes, needs, and perceptions do patients with MASH participating in the MASH-Cardiovascular Programme exhibit before and after the intervention? Participants will undergo two semi-structured interviews: one prior to, and one following, their involvement in the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients who voluntarily agree to participate in the MASH-Cardiovascular Programme. * Patients followed in the outpatient hepatology/gastroenterology clinic at Hospital de Sant Pau with a diagnosis of MASH and fibrosis stage F2-F4. * Patients aged between 18 and 75 years. * Patients with a BMI ≥ 27 kg/m². * Patients who consent to participate in the study-specific interviews. Exclusion Criteria: * Patients who do not agree to participate in the study-specific interviews. * Patients meeting exclusion criteria of the MASH-Cardiovascular Programme: * Patients with decompensated liver cirrhosis. * Patients who are vegetarians or have dietary habits/preferences that prevent adherence to standard-of-care nutritional guidelines. * Patients with moderate-to-severe alcohol consumption (\>20 g/day for women and \>40 g/day for men). * Patients with an eGFR \< 30 mL/min. * Patients with malnutrition. * Patients with type 1 diabetes or other forms of diabetes. * Patients who are candidates for bariatric surgery. * Patients with active malignancy. * Patients with advanced or unstable heart failure. * Patients with eating disorders or severe psychiatric illness. * Patients currently enrolled in another clinical trial. * Pregnant women or women planning to become pregnant.
💊

What it tests

  • Not listed
📍

Where

2 sites
IR Sant Pau
Barcelona, Spain
IR Sant Pau
Barcelona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy